Doss, Catherine2015-10-292015-10-292010-01-25http://hdl.handle.net/10919/63182Compounds developed by researchers at Virginia Tech, have proven effective in destroying breast cancer cells when used with lasers developed by Theralase Technologies (TSX-V: TLT) out of Toronto. Theralase, an international manufacturer of laser medical devices, reports that its patented photodynamic compounds (PDCs) developed at the university, when used with its lasers, destroy breast cancer cells in pre-clinical trials.In CopyrightCollege of SciencePress releaseVirginia Tech. University Relations